“Pharmaceutical Attention in the Treatment of Obesity Involving Analogues of Glucagon-Like Peptide 1 (GPL-1)”. Research, Society and Development, vol. 11, no. 7, May 2022, p. e41011730134, https://doi.org/10.33448/rsd-v11i7.30134.